| Dr Robert J Rapoport, MD | |
|
315 S Manning Blvd, Medical Imaging Department, Albany, NY 12208-1707 | |
| (518) 525-1852 | |
| (518) 525-1559 |
| Full Name | Dr Robert J Rapoport |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 36 Years |
| Location | 315 S Manning Blvd, Albany, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669464780 | NPI | - | NPPES |
| 01766792 | Medicaid | NY | |
| 1017467 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 206239 (New York) | Primary |
| 2085N0700X | Radiology - Neuroradiology | 206239 (New York) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Peter's Hospital | Albany, NY | Hospital |
| Samaritan Hospital | Troy, NY | Hospital |
| Ellis Hospital | Schenectady, NY | Hospital |
| Albany Medical Center Hospital | Albany, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Albany Advanced Imaging Pllc | 1153308820 | 22 |
| Northeast Medical Imaging Pc | 1153310727 | 20 |
| Ellis Hospital | 5890607410 | 222 |
| St. Peter's Health Partners Medical Associates, P.c. | 6103061189 | 393 |
News Archive
The U.S. Court of Appeals for the District of Columbia on Tuesday vacated an earlier decision that would have provided terminally ill patients with expanded access to experimental medications and likely will rehear the case next summer, Dow Jones/Wall Street Journal reports (Wilde Mathews, Dow Jones/Wall Street Journal, 11/21).
ISPOR, the professional society for health economics and outcomes research (HEOR), held an issue panel this afternoon that focused on mHealth in cancer care at its 20th Annual European Congress in Glasgow, Scotland, UK.
Aeolus Pharmaceuticals, Inc. announced today that after review of the Company's white paper on development of AEOL-10150 as a countermeasure for the lung effects of acute radiation syndrome, the Biomedical Advanced Research and Development Authority (BARDA) Division of Chemical, Radiological and Nuclear (CBRN) Countermeasures has informed the Company that, after careful analysis and consideration, it has invited Aeolus to submit a full proposal for a contract to develop AEOL 10150 from its current level of technical readiness to FDA approval.
Boehringer Ingelheim Pharmaceuticals, Inc. announced that clinical trial enrollment has completed for two phase III studies evaluating the safety and efficacy of nintedanib (BIBF 1120), an investigational compound, in patients with idiopathic pulmonary fibrosis (IPF), being studied at a twice-daily oral dose.
A new study recommends healthy children with symptoms of sleep disordered breathing, such as snoring or temporary cessation of breathing, should consider undergoing a sleep study (polysomnography) and should discuss the potential benefits of this with their pediatrician or otolaryngologist to possibly manage the child's symptoms medically and before surgery.
› Verified 4 days ago
| Entity Name | Ellis Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487644993 PECOS PAC ID: 5890607410 Enrollment ID: O20031103000406 |
News Archive
The U.S. Court of Appeals for the District of Columbia on Tuesday vacated an earlier decision that would have provided terminally ill patients with expanded access to experimental medications and likely will rehear the case next summer, Dow Jones/Wall Street Journal reports (Wilde Mathews, Dow Jones/Wall Street Journal, 11/21).
ISPOR, the professional society for health economics and outcomes research (HEOR), held an issue panel this afternoon that focused on mHealth in cancer care at its 20th Annual European Congress in Glasgow, Scotland, UK.
Aeolus Pharmaceuticals, Inc. announced today that after review of the Company's white paper on development of AEOL-10150 as a countermeasure for the lung effects of acute radiation syndrome, the Biomedical Advanced Research and Development Authority (BARDA) Division of Chemical, Radiological and Nuclear (CBRN) Countermeasures has informed the Company that, after careful analysis and consideration, it has invited Aeolus to submit a full proposal for a contract to develop AEOL 10150 from its current level of technical readiness to FDA approval.
Boehringer Ingelheim Pharmaceuticals, Inc. announced that clinical trial enrollment has completed for two phase III studies evaluating the safety and efficacy of nintedanib (BIBF 1120), an investigational compound, in patients with idiopathic pulmonary fibrosis (IPF), being studied at a twice-daily oral dose.
A new study recommends healthy children with symptoms of sleep disordered breathing, such as snoring or temporary cessation of breathing, should consider undergoing a sleep study (polysomnography) and should discuss the potential benefits of this with their pediatrician or otolaryngologist to possibly manage the child's symptoms medically and before surgery.
› Verified 4 days ago
| Entity Name | Northeast Medical Imaging Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396720140 PECOS PAC ID: 1153310727 Enrollment ID: O20040510000121 |
News Archive
The U.S. Court of Appeals for the District of Columbia on Tuesday vacated an earlier decision that would have provided terminally ill patients with expanded access to experimental medications and likely will rehear the case next summer, Dow Jones/Wall Street Journal reports (Wilde Mathews, Dow Jones/Wall Street Journal, 11/21).
ISPOR, the professional society for health economics and outcomes research (HEOR), held an issue panel this afternoon that focused on mHealth in cancer care at its 20th Annual European Congress in Glasgow, Scotland, UK.
Aeolus Pharmaceuticals, Inc. announced today that after review of the Company's white paper on development of AEOL-10150 as a countermeasure for the lung effects of acute radiation syndrome, the Biomedical Advanced Research and Development Authority (BARDA) Division of Chemical, Radiological and Nuclear (CBRN) Countermeasures has informed the Company that, after careful analysis and consideration, it has invited Aeolus to submit a full proposal for a contract to develop AEOL 10150 from its current level of technical readiness to FDA approval.
Boehringer Ingelheim Pharmaceuticals, Inc. announced that clinical trial enrollment has completed for two phase III studies evaluating the safety and efficacy of nintedanib (BIBF 1120), an investigational compound, in patients with idiopathic pulmonary fibrosis (IPF), being studied at a twice-daily oral dose.
A new study recommends healthy children with symptoms of sleep disordered breathing, such as snoring or temporary cessation of breathing, should consider undergoing a sleep study (polysomnography) and should discuss the potential benefits of this with their pediatrician or otolaryngologist to possibly manage the child's symptoms medically and before surgery.
› Verified 4 days ago
| Entity Name | Capital Imaging Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093794513 PECOS PAC ID: 7416939590 Enrollment ID: O20040602001438 |
News Archive
The U.S. Court of Appeals for the District of Columbia on Tuesday vacated an earlier decision that would have provided terminally ill patients with expanded access to experimental medications and likely will rehear the case next summer, Dow Jones/Wall Street Journal reports (Wilde Mathews, Dow Jones/Wall Street Journal, 11/21).
ISPOR, the professional society for health economics and outcomes research (HEOR), held an issue panel this afternoon that focused on mHealth in cancer care at its 20th Annual European Congress in Glasgow, Scotland, UK.
Aeolus Pharmaceuticals, Inc. announced today that after review of the Company's white paper on development of AEOL-10150 as a countermeasure for the lung effects of acute radiation syndrome, the Biomedical Advanced Research and Development Authority (BARDA) Division of Chemical, Radiological and Nuclear (CBRN) Countermeasures has informed the Company that, after careful analysis and consideration, it has invited Aeolus to submit a full proposal for a contract to develop AEOL 10150 from its current level of technical readiness to FDA approval.
Boehringer Ingelheim Pharmaceuticals, Inc. announced that clinical trial enrollment has completed for two phase III studies evaluating the safety and efficacy of nintedanib (BIBF 1120), an investigational compound, in patients with idiopathic pulmonary fibrosis (IPF), being studied at a twice-daily oral dose.
A new study recommends healthy children with symptoms of sleep disordered breathing, such as snoring or temporary cessation of breathing, should consider undergoing a sleep study (polysomnography) and should discuss the potential benefits of this with their pediatrician or otolaryngologist to possibly manage the child's symptoms medically and before surgery.
› Verified 4 days ago
| Entity Name | Albany Advanced Imaging Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871578898 PECOS PAC ID: 1153308820 Enrollment ID: O20040630000901 |
News Archive
The U.S. Court of Appeals for the District of Columbia on Tuesday vacated an earlier decision that would have provided terminally ill patients with expanded access to experimental medications and likely will rehear the case next summer, Dow Jones/Wall Street Journal reports (Wilde Mathews, Dow Jones/Wall Street Journal, 11/21).
ISPOR, the professional society for health economics and outcomes research (HEOR), held an issue panel this afternoon that focused on mHealth in cancer care at its 20th Annual European Congress in Glasgow, Scotland, UK.
Aeolus Pharmaceuticals, Inc. announced today that after review of the Company's white paper on development of AEOL-10150 as a countermeasure for the lung effects of acute radiation syndrome, the Biomedical Advanced Research and Development Authority (BARDA) Division of Chemical, Radiological and Nuclear (CBRN) Countermeasures has informed the Company that, after careful analysis and consideration, it has invited Aeolus to submit a full proposal for a contract to develop AEOL 10150 from its current level of technical readiness to FDA approval.
Boehringer Ingelheim Pharmaceuticals, Inc. announced that clinical trial enrollment has completed for two phase III studies evaluating the safety and efficacy of nintedanib (BIBF 1120), an investigational compound, in patients with idiopathic pulmonary fibrosis (IPF), being studied at a twice-daily oral dose.
A new study recommends healthy children with symptoms of sleep disordered breathing, such as snoring or temporary cessation of breathing, should consider undergoing a sleep study (polysomnography) and should discuss the potential benefits of this with their pediatrician or otolaryngologist to possibly manage the child's symptoms medically and before surgery.
› Verified 4 days ago
| Entity Name | St. Peter's Health Partners Medical Associates, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750626834 PECOS PAC ID: 6103061189 Enrollment ID: O20130321000567 |
News Archive
The U.S. Court of Appeals for the District of Columbia on Tuesday vacated an earlier decision that would have provided terminally ill patients with expanded access to experimental medications and likely will rehear the case next summer, Dow Jones/Wall Street Journal reports (Wilde Mathews, Dow Jones/Wall Street Journal, 11/21).
ISPOR, the professional society for health economics and outcomes research (HEOR), held an issue panel this afternoon that focused on mHealth in cancer care at its 20th Annual European Congress in Glasgow, Scotland, UK.
Aeolus Pharmaceuticals, Inc. announced today that after review of the Company's white paper on development of AEOL-10150 as a countermeasure for the lung effects of acute radiation syndrome, the Biomedical Advanced Research and Development Authority (BARDA) Division of Chemical, Radiological and Nuclear (CBRN) Countermeasures has informed the Company that, after careful analysis and consideration, it has invited Aeolus to submit a full proposal for a contract to develop AEOL 10150 from its current level of technical readiness to FDA approval.
Boehringer Ingelheim Pharmaceuticals, Inc. announced that clinical trial enrollment has completed for two phase III studies evaluating the safety and efficacy of nintedanib (BIBF 1120), an investigational compound, in patients with idiopathic pulmonary fibrosis (IPF), being studied at a twice-daily oral dose.
A new study recommends healthy children with symptoms of sleep disordered breathing, such as snoring or temporary cessation of breathing, should consider undergoing a sleep study (polysomnography) and should discuss the potential benefits of this with their pediatrician or otolaryngologist to possibly manage the child's symptoms medically and before surgery.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert J Rapoport, MD Po Box 14890, Albany, NY 12212-4890 Ph: (518) 525-1550 | Dr Robert J Rapoport, MD 315 S Manning Blvd, Medical Imaging Department, Albany, NY 12208-1707 Ph: (518) 525-1852 |
News Archive
The U.S. Court of Appeals for the District of Columbia on Tuesday vacated an earlier decision that would have provided terminally ill patients with expanded access to experimental medications and likely will rehear the case next summer, Dow Jones/Wall Street Journal reports (Wilde Mathews, Dow Jones/Wall Street Journal, 11/21).
ISPOR, the professional society for health economics and outcomes research (HEOR), held an issue panel this afternoon that focused on mHealth in cancer care at its 20th Annual European Congress in Glasgow, Scotland, UK.
Aeolus Pharmaceuticals, Inc. announced today that after review of the Company's white paper on development of AEOL-10150 as a countermeasure for the lung effects of acute radiation syndrome, the Biomedical Advanced Research and Development Authority (BARDA) Division of Chemical, Radiological and Nuclear (CBRN) Countermeasures has informed the Company that, after careful analysis and consideration, it has invited Aeolus to submit a full proposal for a contract to develop AEOL 10150 from its current level of technical readiness to FDA approval.
Boehringer Ingelheim Pharmaceuticals, Inc. announced that clinical trial enrollment has completed for two phase III studies evaluating the safety and efficacy of nintedanib (BIBF 1120), an investigational compound, in patients with idiopathic pulmonary fibrosis (IPF), being studied at a twice-daily oral dose.
A new study recommends healthy children with symptoms of sleep disordered breathing, such as snoring or temporary cessation of breathing, should consider undergoing a sleep study (polysomnography) and should discuss the potential benefits of this with their pediatrician or otolaryngologist to possibly manage the child's symptoms medically and before surgery.
› Verified 4 days ago
Robert A Belgam, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 113 Holland Ave, Stratton Va Medical Center, Albany, NY 12208 Phone: 518-626-6650 Fax: 518-626-6644 | |
Mr. Sreenivas Garla, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 47 New Scotland Ave, Radiology Dept, Albany, NY 12208 Phone: 518-262-3277 Fax: 518-262-4210 | |
David Jahangir, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 315 S Manning Blvd, Albany, NY 12208 Phone: 518-525-1401 | |
Dr. S Rao Aravapalli, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 47 New Scotland Ave, Dept. Of Radiology, Albany, NY 12208 Phone: 518-262-3277 Fax: 518-262-4210 | |
Dr. Heidi Dambach, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 47 New Scotland Ave, Albany, NY 12208 Phone: 518-262-3277 | |
Sean Peter Roddy, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 391 Myrtle Ave., Suite 5, The Vascular Group, Pllc, Albany, NY 12208 Phone: 518-262-5640 Fax: 518-262-9413 | |
Dena Miller, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 315 S Manning Blvd, Albany, NY 12208 Phone: 518-525-1401 |